Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Aug 18;15(2):e1846. doi: 10.1002/wnan.1846

FIGURE 5.

FIGURE 5

(a) Box-and-Whisker plot of doxorubicin (DOX) concentration in the tumors of KPC mice treated with 15 mg DOX/kg low-temperature-sensitive liposomal doxorubicin (LTSL-DOX) and nonliposomal doxorubicin (DOX), with and without the application of MR-HIFU. *Denotes significance at the p < 0.05 level. (b) Median doxorubicin concentration ([interquartile range] measured in pancreatic tumors following different treatment regimens (n = 4 in each group; Farr et al., 2018)